THE POSSIBILITY OF ADMINISTRATION OF GLUTAMATE RECEPTORS ANTAGONISTS IN THE TREATMENT OF PARKINSON'S DISEASE

• Egile Nagusiak: Natalya Avdeeva (Egilea), Vladislava Nikitina (Egilea), Indira Kochkarova (Egilea), Anna Litvinova (Egilea)
• Formatua: Liburua
• Argitaratua: Belgorod National Research University, 2016-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Parkinson's disease is the slow-progressing chronic neurodegenerative disease. It caused by the progressive destruction and death of neurons that produce the neurotransmitter dopamine, primarily in the substantia nigra and also in other parts of the Central nervous system. Insufficient producti...